Tag: therapeutics

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

April 30, 2025 16:30 ET  | Source: LENZ Therapeutics, Inc. SAN DIEGO,…

GlobeNews Wire GlobeNews Wire
undefined

Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX)…

GlobeNews Wire GlobeNews Wire
undefined

UPDATE — Relmada Therapeutics To Present NDV-01 Data at AUA2025

Data to be presented in Clinical Trials in Progress Session on Monday,…

GlobeNews Wire GlobeNews Wire
undefined

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

April 24, 2025 20:00 ET  | Source: BriaCell Therapeutics Corp. PHILADELPHIA and…

GlobeNews Wire GlobeNews Wire
undefined

Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025

April 24, 2025 01:00 ET  | Source: Addex Therapeutics Geneva, Switzerland, April…

GlobeNews Wire GlobeNews Wire
undefined

Antag Therapeutics expands senior team to support clinical progress

Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”),…

GlobeNews Wire GlobeNews Wire
undefined

Vivoryon Therapeutics N.V. to Report Full Year 2024 Financial Results and Operational Progress on April 29, 2025

Vivoryon Therapeutics N.V. to Report Full Year 2024 Financial Results and Operational…

GlobeNews Wire GlobeNews Wire
undefined

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

April 16, 2025 08:00 ET  | Source: Akari Therapeutics Plc Advancing development…

GlobeNews Wire GlobeNews Wire
undefined

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson’s Disease

HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”)…

GlobeNews Wire GlobeNews Wire
undefined